4.4 Article

Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy

Related references

Note: Only part of the references are listed.
Article Oncology

Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients

Laura S. Mertens et al.

Summary: This study analyzed the expression of FGFR3 gene mutation, p53, and Ki-67 in patients with invasive bladder cancer and evaluated their prognostic value. The results showed that FGFR3 gene mutation was associated with lower tumor stage, lower tumor grade, no lymph node metastasis, and longer disease-specific survival. In contrast, abnormal expression of p53 and Ki-67 was only associated with higher tumor stage and G3 grade tumors. Multivariable analysis showed that besides tumor stage, lympho-vascular invasion, and lymph node stage, FGFR3 gene mutation status was a significant predictor of patient prognosis.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Review Urology & Nephrology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes et al.

Summary: This article presents the updated European Association of Urology guidelines for muscle-invasive and metastatic bladder cancer, providing practical evidence-based recommendations and consensus statements on clinical management. The guidelines cover a broad scope and incorporate the latest research findings and results from consensus meetings.

EUROPEAN UROLOGY (2021)

Article Urology & Nephrology

Timing, Patterns and Predictors of 90-Day Readmission Rate after Robotic Radical Cystectomy

Giovanni E. Cacciamani et al.

Summary: The study examined the 90-day readmission after robotic radical cystectomy and found a significant rate of readmission. In-hospital infections and male gender were identified as independent factors for readmission, with most readmissions occurring within the first 2 weeks post-discharge, mainly due to metabolic derangements and infections.

JOURNAL OF UROLOGY (2021)

Review Nutrition & Dietetics

Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review

Sorayya Kheirouri et al.

Summary: The study found that a high preoperative CONUT score is associated with a poor survival rate in cancer patients, and is an independent prognostic factor. The CONUT score shows a high prognostic competence in predicting OS, CSS, and RFS.

ADVANCES IN NUTRITION (2021)

Article Urology & Nephrology

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: A Multicentre Comparative Effectiveness Study

Carl J. Wijburg et al.

Summary: This study did not find significant differences in complications and health-related quality of life between robot-assisted radical cystectomy and open radical cystectomy. However, there were some differences in secondary outcomes, with the main limitation being residual confounding.

EUROPEAN UROLOGY (2021)

Article Oncology

The Controlling Nutritional Status (CONUT) Score is a Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with First-Line Platinum-Based Chemotherapy

Hiroaki Suzuki et al.

Summary: The CONUT score, calculated from serum albumin, total cholesterol, and total lymphocyte count, is a prognostic biomarker in patients with advanced urothelial carcinoma (aUC) receiving first-line platinum-based chemotherapy. A higher CONUT score was independently associated with shorter overall survival (OS) along with other clinical parameters such as poorer performance status, primary tumor site of the upper urinary tract, and non-responsiveness to chemotherapy.

BLADDER CANCER (2021)

Article Oncology

Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy

Francesco Claps et al.

Summary: The study evaluated the prognostic role of albumin-to-fibrinogen ratio (AFR) in bladder cancer patients undergoing radical cystectomy (RC), with preoperative low AFR independently associated with worse outcomes. These results suggest that patients with low AFR may benefit from neoadjuvant treatment.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Review Urology & Nephrology

Molecular markers of systemic therapy response in urothelial carcinoma

Francesco Claps et al.

Summary: Identifying reliable molecular biomarkers to complement clinical practice is a challenging task, particularly in the heterogeneous disease of urothelial carcinoma. Advances in molecular biology offer promising platforms to understand the biology behind the disease.

ASIAN JOURNAL OF UROLOGY (2021)

Article Medicine, Research & Experimental

The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy

Yuki Nemoto et al.

Summary: The CONUT score can serve as an effective predictor for survival and tolerability in patients undergoing RC for advanced BC. Patients in the high CONUT group demonstrated significantly shorter RFS, CSS, and OS. The CONUT score was found to be an independent prognostic factor for RFS, CSS, and OS.

IN VIVO (2021)

Review Oncology

Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients

Sarah P. Psutka et al.

EUROPEAN UROLOGY ONCOLOGY (2018)

Article Oncology

Perioperative Therapy for Muscle Invasive Bladder Cancer

Jeffrey J. Leow et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)